Basic approach for good prescribing: Post-translational modulation of activities of drug-metabolizing enzymes
Basic approach for good prescribing: Post-translational modulation of activities of drug-metabolizing enzymes
批准号:
17590128
负责人:
ISHII Yuji
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
研究了药物代谢酶活性的翻译后调节。以下是该项目的成果。1)CYP 1A 2和CYP 2C 9能够修饰UGT 2B 7功能。然而,这些P450调节UGT 2B 7功能的潜在机制似乎与CYP 3A 4不同。2)通过免疫沉淀、重叠试验和使用交联剂1-乙基-3-[3-(二甲氨基)丙基]碳二亚胺(EDC)进行交联,更详细地证明了CYP 3A 4-UGT 2B 7的结合。3)确定了在与UGT 2B 7相互作用中发挥作用的CYP 3A 4候选区域。4)酮康唑通过竞争性和非竞争性抑制等新机制抑制吗啡UGT。5)在大鼠中也发现了P450-UGT的关联。有人认为,这种相互作用是保守的物种。6)酰基辅酶A作为UGT的内源性激活剂发挥作用。7)存在于内质网内的许多细胞核苷酸调节UGT功能。这些物质与UGT上的一个共同的变构位点结合,从而降低了UGT的催化功能,提示P450与UGT之间存在功能性相互作用。此外,内源性调节剂对UGT也可能是重要的。有必要进一步研究以阐明CYP 3A 4和UGT 2B 7之间的相互作用对UGT 2B 7体内催化反应的影响。
英文摘要
Post-translational modulation of activities of drug-metabolizing enzymes was studied. Followings are outcomes from this project. 1) CYP1A2 and CYP2C9 have ability to modify UGT2B7 function. However, the mechanism(s) underlying the modulation of UGT2B7 function by these P450s seems to differ from that by CYP3A4. 2) CYP3A4-UGT2B7 association was demonstrated in more detail by means of immunoprecipitation, overlay assay and cross-linking with a cross-linker, 1-ethyl-3-[3- (dimethylamino)propyl]carbodiimide (EDC). 3) The candidate region of CYP3A4 which plays a role in the interaction with UGT2B7 was determined. 4) Ketoconazole exerts its inhibitory effect on morphine UGT by novel mechanisms involving competitive and noncompetitive inhibition. 5) P450-UGT association was also found in rats. It was suggested that such interaction is conserved from species to species. 6) Acyl-CoAs play a role as an endogenous activator of UGTs. 7) A number of cellular nucleotides present within the endoplasmic reticulum regulate UGT function. Further these substances bind to a common allosteric site on UGT to reduce catalytic function.These results suggest that there are functional interaction between P450 and UGT. In addition, endogenous modulators may also important for UGT. Further study is necessary to clarify the impact of interaction between CYP3A4 and UGT2B7 on UGT2B7-catalyzed reaction in vivo.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Fatty acyl-CoA as an endogenous activator of UDP-glucuronosyltransferases
脂肪酰辅酶A作为UDP-葡萄糖醛酸基转移酶的内源性激活剂
DOI:
--
发表时间:
2006
期刊:
Biochem. Biophys. Res. Commn. 345
影响因子:
--
作者:
[Okamura, et al]
通讯作者:
et al
DOI:
10.1248/bpb.28.2026
发表时间:
2005-10-01
期刊:
BIOLOGICAL & PHARMACEUTICAL BULLETIN
影响因子:
2
作者:
[Takeda, S, Ishii, Y, Yamada, H]
通讯作者:
Yamada, H
Bas i s stud i es on the appropr i ate usage of c l i n i ca I med i c i ne : i so form specificity of the functional interaction between drug metabolizing enzymes and the individual differences
-
批准号:21590164
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:ISHII Yuji
-
依托单位:
Basic Studies on the appropriate usage of clinical narcotics : the individual differences in the formation of morphine active metabolite which is not dependent on the genetic polymorphism
-
批准号:19590147
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:ISHII Yuji
-
依托单位:
Significance of inflammatory mediators in hepatocellular carcinoma
-
批准号:18591525
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.53万
-
财政年份:2006
-
负责人:ISHII Yuji
-
依托单位:
Clinical Application of Anti-angiogenetic Therapy on Hepatocarcinogenesis and Hepatocellular carcinoma -With Special Reference to Matrix Metalloproteinases and Cytokines network-
-
批准号:12671268
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:ISHII Yuji
-
依托单位:
The effect of an angiogenesis inhibitor (FR-118487) on rat experimental hepatoma -Immunohistological analysis-
-
批准号:07671429
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1995
-
负责人:ISHII Yuji
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MYB/CsATL15-UGT调控茶树黄酮醇苷合成的机制解析
-
批准号:QN25C060003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:方瀚墨
-
依托单位:
柑桔全爪螨UGT202A7过表达介导阿维菌素抗性的分子调控机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:袁国瑞
-
依托单位:
UGT1A1基因启动子区甲基化调控神经元铁死亡水平影响新生儿高胆
红素血症脑损伤的分子机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:闫军
-
依托单位:
平滑肌细胞内源性CSE/H2S通过Ugt1a6调节线粒体功能参与动脉硬化的分子机制
-
批准号:82370448
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:耿彬
-
依托单位:
LncRNA SRA1/SPTBN1复合物调控UGT1A家族增加药物水溶性促进Her-2阳性乳腺癌新辅助化疗耐药
-
批准号:32360144
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:罗清
-
依托单位:
基于人UGT1A4催化葡萄糖醛酸化代谢的含吡咯里西啶生物碱中药安全性评价
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:熊爱珍
-
依托单位:
H2S通过线粒体Ugt1a6调节血管平滑肌硬化参与高血压发生的作用和机制
-
批准号:82300504
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:邓越
-
依托单位:
miR-275靶向UGT2介导褐飞虱适应抗性水稻的分子机制
-
批准号:32372548
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:刘清松
-
依托单位:
UGT72B66介导水杨酸甲酯糖苷化调控茶树抗寒的分子机制
-
批准号:32302606
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:赵明月
-
依托单位:
番茄UGT73C4介导果实柚皮苷合成的分子机制研究
-
批准号:32302547
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王妍
-
依托单位: